New cancer treatment approach could help immune cells fight tumors longer
UCLA researchers found that boosting p53 protein with navtemadlin helped T cells fight melanoma cancer cells longer, but dosing challenges remain.
Covered by 1 source ·
Every side
-
Fox News
UCLA researchers found that boosting p53 protein with navtemadlin helped T cells fight melanoma cancer cells longer, but dosing challenges remain.